Michael Tentilucci
Associate
Mike Tentilucci joined Ropes & Gray's corporate department in 2021. Mike focuses his practice on representing companies and investment banks in public offerings, strategic transactions and corporate governance matters.
Experience
Mike has represented:
- Cyteir Therapeutics, Inc. in its initial public offering, as well as ongoing disclosure and governance matters.
- RVL Pharmaceuticals plc in equity offerings, as well as ongoing disclosure and governance matters.
- Novavax, Inc. in equity offerings, as well as ongoing disclosure and governance matters.
- the lead underwriters in the initial public offering of byNordic Acquisition Corporation.
- the lead underwriters in the initial public offering of CIIG Capital Partners II, Inc.
- the lead underwriters in the initial public offering of Tio Tech A.
- an investment manager in the Series B financing for Breeze Aviation Group, Inc.
- Pfizer Inc. in its acquisition of Trillium Therapeutics.
- Acceleron Pharma Inc. in its sale to Merck.
Education
- JD, cum laude, William & Mary Law School, 2020
- BS (Chemistry), Haverford College, 2015
Admissions / Qualifications
Qualifications
- New York, 2021